FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Updates Examples of Medical Device Misconnections

[ Price : $8.95]

FDA adds a new case study to its Examples of Medical Device Misconnections Web page.

FDA Exploring New Device Active Surveillance System

[ Price : $8.95]

FDA posts a sources sought information request that seeks potential contractors who may be able to develop and implement a medical...

FDA Evaluating Neonatal Incubator Airborne Chemicals

[ Price : $8.95]

FDA says it is evaluating reports of exposure to airborne chemicals that may be associated with the use of neonatal incubators.

USPTO Should Check Keytruda Patent Requests: Lawmakers

[ Price : $8.95]

Four Democrat senators and representatives say the U.S. Patent and Trademark Office should weigh a new Merck patent request for a ...

Amneal Pharmaceuticals FDA-483 Released

[ Price : $8.95]

FDA releases the form FDA-483 issued following an inspection at the Ahmedabad, India-based Amneal Pharmaceuticals Private Limited ...

Lessons Learned from Covid Vaccine Development

[ Price : $8.95]

CBER director Peter Marks discusses four lessons learned from the rapid development of Covid-19 vaccines and the implications for ...

Asacol Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Allergans Asacol HD (mesalamine) delayed-release tablet, 800 mg, was not withdrawn du...

Topamax Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determined that Janssens Topamax (topiramate) sprinkle capsules, 50 mg, was not withdrawn due to safe...

AAM Praises Controlled Correspondence Guidance

[ Price : $8.95]

The Association for Accessible Medicines praises the FDA revision of a draft guidance on generic drug controlled correspondence to...

FDA Publishes 3 X-Ray Guidances

[ Price : $8.95]

FDA publishes three guidances on aspects of x-ray system regulation.